Our findings indicated that FAK is downregulated by the activation of the Wnt/β-catenin pathway, as described in human mesothelioma cells and in prostate cancer models, where the inactivation of Wnt produced the activation of FAK [29,30]. This evidence concerns the gene PTK2 and prostate carcinoma.